US: Pfizer, BioNTech seek vaccine authorisation for 12 to 15-year olds
Pfizer and BioNTech cited research unveiled last month that found its vaccine is 100 percent effective in children ages 12 to 15. Pfizer and BioNTech requested the US Food and Drug Administration (FDA) on Friday for an amendment to its emergency use authorization of its Covid-19 vaccine, to expand its use for children ages 12 … Read more